Publication | Open Access

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

Noncovalent Nanomolar InhibitorsMedicineAntiviral TherapyAntiviral DrugPharmacologyAntiviral CompoundInduced-fit BindingDrug DiscoveryCovid-19